RxDoctor Payments Data

James Shumate, DO

Family Medicine · Jacksonville, NCNPI 1649267220

Payments from drug & device makers

$4,233in general payments, 2019–2025

Across 288 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$808
  • Novo Nordisk$499
  • AstraZeneca$340
  • Lilly USA, LLC$315
  • GSK$248
  • Pfizer$232
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$4,233100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,233 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$142,722
Medicare patients
334
Services billed
2,057

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide119$140,689
JardianceEmpagliflozin134$108,663
EnbrelEtanercept14$101,831
EliquisApixaban98$75,891
Trelegy ElliptaFluticasone/Umeclidin/Vilanter68$65,640
MounjaroTirzepatide49$62,014
JanuviaSitagliptin Phosphate48$50,632
LinzessLinaclotide62$39,225
TrulicityDulaglutide42$37,279
VraylarCariprazine Hcl14$33,425
Xtampza ErOxycodone Myristate59$27,840
Bydureon BciseExenatide Microspheres24$22,431
Nurtec OdtRimegepant Sulfate20$20,095
XareltoRivaroxaban24$19,648
FarxigaDapagliflozin Propanediol25$18,365

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$499$151,735131 claims
Boehringer IngelheimJardiance, Tradjenta, Glyxambi, Stiolto Respimat$17$150,046182 claims
PfizerEliquis, Nurtec Odt, Premarin$232$102,751144 claims
AmgenEnbrel$100$101,83114 claims
Lilly USA, LLCMounjaro, Trulicity$315$99,29391 claims
AbbVieLinzess, Vraylar, Restasis$808$80,44688 claims
MerckJanuvia, Steglujan, Janumet Xr$68$70,72178 claims
GSKTrelegy Ellipta, Incruse Ellipta$248$70,27681 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$340$38,44174 claims
Collegium Pharmaceutical, Inc.Xtampza Er$24$27,84059 claims
Astellas Pharma US IncMyrbetriq, Veozah$208$23,58139 claims
NovartisEntresto$115$16,20525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Jacksonville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →